Pharmacogenomics in drug development – Impact, Facilitate and Educate!
Who We Are
The Industry Pharmacogenomics Working Group (I-PWG) was established in 2000 and is comprised of functionally diverse members from pharmaceutical and biotechnology companies. Our diverse membership is made up of those engaging in regulatory, statistical, technological , genomic and biological research as well as operations. We engage pre-competitively to address emerging issues related to pharmacogenomics.